Crewe Advisors’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$20.4K Sell
739
-675
-48% -$18.6K ﹤0.01% 363
2025
Q1
$40.1K Hold
1,414
0.01% 287
2024
Q4
$58.8K Sell
1,414
-46
-3% -$1.91K 0.01% 266
2024
Q3
$97.6K Hold
1,460
0.01% 232
2024
Q2
$173K Sell
1,460
-104
-7% -$12.4K 0.02% 187
2024
Q1
$167K Buy
+1,564
New +$167K 0.02% 193
2023
Q4
Sell
-676
Closed -$69.8K 596
2023
Q3
$69.8K Sell
676
-1
-0.1% -$103 0.01% 120
2023
Q2
$82.3K Sell
677
-15
-2% -$1.82K 0.01% 220
2023
Q1
$106K Sell
692
-29
-4% -$4.45K 0.02% 221
2022
Q4
$130K Sell
721
-107
-13% -$19.2K 0.02% 196
2022
Q3
$98K Buy
828
+53
+7% +$6.27K 0.02% 227
2022
Q2
$111K Buy
775
+100
+15% +$14.3K 0.02% 196
2022
Q1
$116K Hold
675
0.02% 163
2021
Q4
$171K Hold
675
0.03% 95
2021
Q3
$260K Hold
675
0.06% 57
2021
Q2
$159K Hold
675
0.04% 85
2021
Q1
$88K Hold
675
0.02% 114
2020
Q4
$71K Buy
+675
New +$71K 0.03% 112